Phenobarb 130mg/ml Inj, 1ml

Manufacturer WEST-WARD Active Ingredient Phenobarbital Injection (IM or IV)(fee noe BAR bi tal) Pronunciation fee noe BAR bi tal
WARNING: The use of this drug along with opioid drugs may lead to severe side effects. This includes feeling very sleepy, slow or trouble breathing, passing out, and death. Opioid drugs include drugs like codeine, oxycodone, and morphine. Opioid drugs are used to treat pain and some are used to treat cough. If you have questions, talk with the doctor.If you are taking this drug with an opioid drug, get medical help right away if you feel very sleepy or dizzy; if you have slow, shallow, or trouble breathing; or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up. Using this drug for reasons that are not approved may increase the risk for drug use disorder. Misuse or abuse of this drug can lead to overdose or death, especially if used with certain other drugs, alcohol, or street drugs. Get medical help right away if you have changes in mood or behavior, suicidal thoughts or actions, seizures, or trouble breathing. @ COMMON USES: It is used to help control certain kinds of seizures.It is used to treat anxiety.It is used to treat sleep problems.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anticonvulsant, Sedative-Hypnotic
đŸ§Ŧ
Pharmacologic Class
Barbiturate
🤰
Pregnancy Category
Category D
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Schedule IV

Overview

â„šī¸

What is this medicine?

Phenobarbital is a medication that works on your brain to calm overactive nerve signals. It's used to control seizures (like in epilepsy) or to help you relax and sleep. It's a strong medicine that can make you feel very sleepy.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to follow the dosage instructions carefully. This medication is administered via injection, either into a muscle or a vein, as directed by your healthcare provider.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

Missing a Dose

If you miss a dose, contact your doctor immediately to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Avoid alcohol and other sedatives, as they can increase drowsiness and breathing problems.
  • Do not drive or operate heavy machinery until you know how this medication affects you, as it can cause significant drowsiness and impaired coordination.
  • Do not stop taking this medication suddenly, especially if you've been on it for a long time, as this can cause severe withdrawal symptoms or seizures. Your doctor will guide you on how to slowly reduce the dose.
  • Inform your doctor about all other medications, supplements, and herbal products you are taking, as phenobarbital can interact with many drugs.
  • Maintain good oral hygiene, as some anticonvulsants can affect gum health (though less common with phenobarbital than phenytoin).

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Status Epilepticus: Loading dose 15-20 mg/kg IV (max 1000 mg/dose), administered at a rate of 50-100 mg/min. Maintenance dose 1-3 mg/kg/day IV/IM/PO, usually given once daily or in divided doses.
Dose Range: 1 - 20 mg

Condition-Specific Dosing:

statusEpilepticusLoading: 15-20 mg/kg IV (max 1000 mg/dose), administer at 50-100 mg/min
statusEpilepticusMaintenance: 1-3 mg/kg/day IV/IM/PO, once daily or divided
sedation: 30-120 mg/day IM/PO in 2-3 divided doses
đŸ‘ļ

Pediatric Dosing

Neonatal: Status Epilepticus: Loading dose 15-20 mg/kg IV (max 40 mg/kg total), administered at 1-3 mg/kg/min. Maintenance dose 3-5 mg/kg/day IV/IM/PO, once daily or divided.
Infant: Status Epilepticus: Loading dose 15-20 mg/kg IV (max 40 mg/kg total), administered at 1-3 mg/kg/min. Maintenance dose 5-6 mg/kg/day IV/IM/PO, once daily or divided.
Child: Status Epilepticus: Loading dose 15-20 mg/kg IV (max 40 mg/kg total), administered at 1-3 mg/kg/min. Maintenance dose 4-5 mg/kg/day IV/IM/PO, once daily or divided.
Adolescent: Status Epilepticus: Loading dose 15-20 mg/kg IV (max 1000 mg/dose), administered at 50-100 mg/min. Maintenance dose 1-3 mg/kg/day IV/IM/PO, once daily or divided.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment, monitor for increased sedation.
Moderate: Consider 25% dose reduction, monitor serum levels and clinical response.
Severe: Consider 50% dose reduction, monitor serum levels and clinical response closely. Avoid if possible.
Dialysis: Hemodialysis removes phenobarbital. Supplemental dose may be required after dialysis. Peritoneal dialysis removes phenobarbital slowly.

Hepatic Impairment:

Mild: No specific adjustment, monitor for increased sedation.
Moderate: Consider 25-50% dose reduction, monitor serum levels and clinical response.
Severe: Consider 50% or greater dose reduction, monitor serum levels and clinical response closely. Avoid if possible.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Phenobarbital is a barbiturate that produces nonselective depression of the central nervous system (CNS). It binds to the GABA-A receptor complex, enhancing the inhibitory effects of GABA by prolonging the opening of chloride channels, leading to neuronal hyperpolarization and decreased neuronal excitability. At high concentrations, it may also directly activate chloride channels.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV), 80-90% (IM)
Tmax: IV: <30 minutes (peak effect), IM: 4-12 hours
FoodEffect: Not applicable for injection; oral absorption not significantly affected by food.

Distribution:

Vd: 0.5-1 L/kg
ProteinBinding: 20-45%
CnssPenetration: Yes

Elimination:

HalfLife: Adults: 50-120 hours; Children: 20-60 hours; Neonates: 100-500 hours
Clearance: Not available (highly variable)
ExcretionRoute: Renal (primarily as inactive metabolites, 25-50% unchanged drug)
Unchanged: 25-50%
âąī¸

Pharmacodynamics

OnsetOfAction: IV: 5 minutes; IM: 30 minutes
PeakEffect: IV: <30 minutes; IM: 30-60 minutes
DurationOfAction: 6-10 hours (anticonvulsant effect can last longer due to long half-life)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Confusion
Balance problems
Muscle spasms
Bad dreams
Restlessness
Hallucinations (seeing or hearing things that are not there)
Shortness of breath
Slow heartbeat
Feeling extremely tired or weak
Severe dizziness or fainting

Severe Skin Reaction (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis)

This rare but serious condition can cause severe health problems and may be life-threatening. Seek medical help immediately if you experience:

Red, swollen, blistered, or peeling skin (with or without fever)
Red or irritated eyes
Sores in your mouth, throat, nose, or eyes

Blood Disorder and Organ Damage

A severe and potentially life-threatening effect has occurred in people taking seizure medications like this one. Contact your doctor right away if you experience:

Swollen glands
Fever
Rash
Painful sores in the mouth or around the eyes
Chest pain
Signs of kidney problems, such as:
+ Unable to pass urine
+ Change in the amount of urine passed
Signs of liver problems, such as:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes

Administration-Related Side Effects

If this medication is administered too quickly, it can cause:

Breathing difficulties
Signs of high or low blood pressure, such as:
+ Severe headache
+ Dizziness
+ Fainting
+ Changes in vision

Tell your doctor immediately if you experience any of these symptoms.

Tissue Damage

If the medication leaks from the vein, it can cause tissue damage. Inform your nurse if you notice:

Redness
Burning
Pain
Swelling
Blisters
Skin sores
Fluid leakage at the injection site

Other Side Effects

Most people do not experience significant side effects, but some may occur. Contact your doctor or seek medical help if you experience any of the following:

Dizziness or drowsiness
Headache
Upset stomach or vomiting
Constipation
Feeling nervous or excitable
Sleep disturbances
* Irritation at the injection site

These are not all the possible side effects that may occur. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe drowsiness or difficulty waking up
  • Slow or shallow breathing
  • Unusual weakness or fatigue
  • Confusion or agitation
  • Skin rash, hives, or blistering (especially with fever or swollen glands)
  • Yellowing of the skin or eyes (jaundice)
  • Unusual bleeding or bruising
  • Fever, sore throat, or other signs of infection
  • Severe dizziness or loss of balance
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Describe the allergic reaction and its symptoms.
Existing health conditions, such as liver disease or breathing difficulties (e.g., shortness of breath).
A history of porphyria, a rare genetic disorder.
Certain heart conditions, including:
+ Heart failure
+ Unstable angina (a type of chest pain)
+ Abnormal heartbeat (e.g., long QT interval on an electrocardiogram (ECG))
+ Kidney disease
+ Low thyroid function (hypothyroidism)
+ Aortic stenosis (a very narrow heart valve)
Recent heart attack
Use of medications that can cause abnormal heart rhythms (prolonged QT interval). There are many medications that can have this effect; consult your doctor or pharmacist if you are unsure.

Special Considerations for Newborns and Infants:

Some formulations of this medication may contain benzyl alcohol, which can cause severe and potentially life-threatening side effects in newborns and infants. Your doctor will weigh the benefits and risks of using this medication in these age groups.

Interactions with Other Medications and Health Conditions:

This is not an exhaustive list of all potential interactions. It is crucial to inform your doctor and pharmacist about all your medications, including:
+ Prescription and over-the-counter (OTC) medications
+ Natural products
+ Vitamins
Share information about your health problems to ensure safe use of this medication.
Do not start, stop, or change the dose of any medication without consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, about your treatment.

Risk of Dependence and Withdrawal
The longer you take this medication and the higher the dose, the greater your risk of dependence and withdrawal. Before reducing the dose or stopping the medication, consult your doctor and follow their instructions carefully. Abruptly lowering the dose or stopping the medication can lead to withdrawal, which may be life-threatening. Seek immediate medical attention if you experience any adverse effects.

Tolerance
If you have been taking this medication for an extended period or at high doses, you may develop tolerance, requiring higher doses to achieve the same effect. If you notice the medication is not working as well as it previously did, contact your doctor. Do not take more than the prescribed dose.

Monitoring and Precautions
If you are taking this medication long-term, your doctor may recommend regular blood tests. Discuss this with your doctor. Until you understand how this medication affects you, avoid driving and other activities that require alertness. Additionally, refrain from consuming alcohol while taking this medication.

Interactions with Other Substances
Before using marijuana, other forms of cannabis, or prescription or over-the-counter drugs that may cause drowsiness, consult your doctor.

Suicidal Thoughts and Actions
Like other seizure medications, this drug may rarely increase the risk of suicidal thoughts or actions, particularly in individuals with a history of such behaviors. Immediately contact your doctor if you experience new or worsening symptoms, such as depression, nervousness, restlessness, irritability, panic attacks, or mood changes. If you have suicidal thoughts or actions, seek medical attention right away.

Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. When used in children, this medication requires careful consideration, as the risk of certain side effects may be higher.

Birth Control and Pregnancy
Birth control pills and other hormone-based birth control methods may be less effective while taking this medication. Use two forms of birth control to prevent pregnancy. If you become pregnant or are planning to become pregnant, inform your doctor, as this medication may harm the unborn baby. If you take this medication during the third trimester of pregnancy, your newborn may experience side effects or withdrawal.

Breastfeeding
If you are breastfeeding, consult your doctor to discuss potential risks to your baby.

Seizure Management
If your seizures change or worsen after starting this medication, consult your doctor to adjust your treatment plan as needed.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Slow, shallow, or absent breathing (respiratory depression)
  • Low blood pressure (hypotension)
  • Slow heart rate (bradycardia)
  • Hypothermia (low body temperature)
  • Pulmonary edema
  • Kidney failure
  • Shock

What to Do:

Seek immediate emergency medical attention. Call 911 or Poison Control at 1-800-222-1222. Management includes supportive care, maintaining airway and breathing, IV fluids, and sometimes activated charcoal (if oral ingestion) or hemodialysis in severe cases.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Porphyria (acute intermittent porphyria)
🔴

Major Interactions

  • Other CNS depressants (e.g., opioids, benzodiazepines, alcohol, tricyclic antidepressants, antihistamines) - increased sedation and respiratory depression
  • Valproic acid - increases phenobarbital levels (inhibits metabolism), leading to toxicity
  • Chloramphenicol - increases phenobarbital levels
  • Oral contraceptives - decreased efficacy of contraceptives (phenobarbital is a strong enzyme inducer)
  • Warfarin - decreased anticoagulant effect (phenobarbital induces metabolism of warfarin)
  • Corticosteroids - decreased corticosteroid effect
  • Doxycycline - decreased doxycycline levels
  • Griseofulvin - decreased griseofulvin levels
  • Lamotrigine - decreased lamotrigine levels
  • Tiagabine - decreased tiagabine levels
  • Felbamate - increased phenobarbital levels
🟡

Moderate Interactions

  • Carbamazepine - decreased phenobarbital levels (enzyme induction), decreased carbamazepine levels
  • Phenytoin - variable effect on phenobarbital levels (can increase or decrease), decreased phenytoin levels
  • Rifampin - decreased phenobarbital levels
  • Theophylline/Aminophylline - decreased theophylline/aminophylline levels
  • Verapamil - increased phenobarbital levels
  • Disulfiram - increased phenobarbital levels
đŸŸĸ

Minor Interactions

  • Folic acid - may decrease phenobarbital levels or increase seizure frequency in some patients

Monitoring

đŸ”Ŧ

Baseline Monitoring

Liver Function Tests (ALT, AST, ALP, Bilirubin)

Rationale: To assess baseline hepatic function as phenobarbital is metabolized by the liver and can cause hepatotoxicity.

Timing: Prior to initiation of therapy.

Renal Function Tests (BUN, Creatinine)

Rationale: To assess baseline renal function as a significant portion of phenobarbital is renally excreted.

Timing: Prior to initiation of therapy.

Complete Blood Count (CBC) with differential

Rationale: To assess for baseline hematologic abnormalities, as phenobarbital can rarely cause blood dyscrasias.

Timing: Prior to initiation of therapy.

Phenobarbital Serum Levels

Rationale: To establish baseline and guide initial dosing, especially in complex cases or when rapid therapeutic levels are needed.

Timing: After loading dose, or 2-3 days after initiation of maintenance therapy.

📊

Routine Monitoring

Phenobarbital Serum Levels

Frequency: Weekly during initial stabilization, then every 1-3 months, or as clinically indicated (e.g., dose change, suspected toxicity, loss of efficacy).

Target: 15-40 mcg/mL (for anticonvulsant effect); lower for sedation.

Action Threshold: Levels >40 mcg/mL associated with increased toxicity (sedation, nystagmus, ataxia); levels <15 mcg/mL may indicate subtherapeutic dosing.

Clinical Assessment (Sedation, Respiratory Rate, Mental Status, Ataxia, Nystagmus)

Frequency: Daily during acute phase, then regularly at follow-up visits.

Target: Alertness appropriate for clinical condition, stable respiratory rate, absence of excessive sedation or motor impairment.

Action Threshold: Excessive sedation, respiratory depression (<12 breaths/min in adults), severe ataxia, nystagmus, or altered mental status warrant immediate dose reduction or discontinuation.

Liver Function Tests (ALT, AST, ALP, Bilirubin)

Frequency: Every 6-12 months, or if signs/symptoms of hepatic dysfunction develop.

Target: Within normal limits.

Action Threshold: Significant elevation (e.g., >3x ULN) warrants investigation and potential dose adjustment or discontinuation.

Complete Blood Count (CBC) with differential

Frequency: Every 6-12 months, or if signs/symptoms of hematologic abnormalities (e.g., fever, sore throat, bruising) develop.

Target: Within normal limits.

Action Threshold: Significant abnormalities (e.g., leukopenia, thrombocytopenia, anemia) warrant investigation and potential discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Excessive sedation
  • Drowsiness
  • Dizziness
  • Ataxia (unsteadiness)
  • Nystagmus (involuntary eye movements)
  • Respiratory depression (slow, shallow breathing)
  • Confusion
  • Irritability
  • Skin rash (Stevens-Johnson syndrome, toxic epidermal necrolysis)
  • Fever
  • Sore throat
  • Unusual bleeding or bruising
  • Yellowing of skin or eyes (jaundice)

Special Patient Groups

🤰

Pregnancy

Phenobarbital is classified as Pregnancy Category D, indicating positive evidence of human fetal risk. It is associated with an increased risk of major congenital malformations (e.g., cardiac defects, cleft lip/palate, neural tube defects) and a fetal barbiturate withdrawal syndrome if used during the third trimester. Use only if the potential benefit outweighs the risk.

Trimester-Specific Risks:

First Trimester: Increased risk of major congenital malformations (e.g., cardiac defects, cleft lip/palate, neural tube defects). Folic acid supplementation is recommended for women of childbearing potential.
Second Trimester: Continued risk of malformations, though less critical period for major organogenesis. Potential for developmental neurotoxicity.
Third Trimester: Risk of neonatal withdrawal syndrome (irritability, hypertonia, tremors, feeding difficulties) and hemorrhagic disease of the newborn (due to vitamin K deficiency). Vitamin K supplementation for the mother in the last month of pregnancy or for the neonate at birth is recommended.
🤱

Lactation

Phenobarbital is excreted into breast milk and can cause significant sedation, poor feeding, and withdrawal symptoms in breastfed infants. The American Academy of Pediatrics considers it a drug for which the effect on nursing infants is unknown but may be of concern. Use with caution; monitor infant for sedation, poor weight gain, and developmental milestones. Consider alternative agents or bottle feeding if infant effects are significant.

Infant Risk: Moderate risk (L3). Potential for sedation, lethargy, poor suckling, and withdrawal symptoms upon discontinuation of breastfeeding.
đŸ‘ļ

Pediatric Use

Neonates and infants have a prolonged half-life due to immature hepatic metabolism, requiring careful dosing and monitoring. Children generally metabolize phenobarbital faster than adults, often requiring higher mg/kg doses. Close monitoring of serum levels and clinical response is crucial due to age-dependent pharmacokinetic variability.

👴

Geriatric Use

Elderly patients may be more sensitive to the CNS depressant effects of phenobarbital (e.g., sedation, ataxia, confusion) and are at increased risk of falls. Lower initial doses and slower titration are recommended. Monitor renal and hepatic function closely, as age-related decline in these functions can prolong phenobarbital's half-life.

Clinical Information

💎

Clinical Pearls

  • Phenobarbital has a very long half-life, meaning it takes a long time to reach steady state (weeks) and to be eliminated from the body. This makes dose adjustments slow and requires patience.
  • Therapeutic drug monitoring (TDM) is essential for phenobarbital to ensure efficacy and minimize toxicity, especially given its narrow therapeutic index.
  • IV administration should be slow (50-100 mg/min in adults, 1-3 mg/kg/min in children) to avoid respiratory depression and hypotension.
  • Due to its enzyme-inducing properties, phenobarbital can significantly reduce the effectiveness of many other medications, including oral contraceptives, warfarin, and other anticonvulsants. Always review concomitant medications.
  • Abrupt discontinuation can precipitate severe withdrawal symptoms, including status epilepticus. Tapering is crucial.
  • While effective, its significant sedative effects and drug interactions have led to its decreased use as a first-line agent for chronic seizure management, but it remains a critical drug for status epilepticus.
🔄

Alternative Therapies

  • For Status Epilepticus: Lorazepam, Diazepam, Midazolam, Fosphenytoin, Levetiracetam, Valproic acid.
  • For Seizure Prophylaxis: Carbamazepine, Phenytoin, Valproic acid, Levetiracetam, Lamotrigine, Topiramate, Oxcarbazepine, Gabapentin, Pregabalin, Zonisamide, Lacosamide.
  • For Sedation/Hypnosis: Benzodiazepines (e.g., Lorazepam, Diazepam, Midazolam), Propofol, Dexmedetomidine.
💰

Cost & Coverage

Average Cost: Not available (highly variable, depends on pharmacy and contract) per 1ml vial
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Properly dispose of unused or expired medications by checking with your pharmacist for guidance on the best disposal method. Unless instructed to do so, avoid flushing medications down the toilet or pouring them down the drain, as this can harm the environment. Many communities have drug take-back programs; your pharmacist can provide information on these programs. Some medications may come with an additional patient information leaflet; consult your pharmacist if you have questions. If you have concerns or questions about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred to ensure prompt and effective treatment.